RhumbLine Advisers
VANI icon

RhumbLine Advisers’s Vivani Medical VANI Stock Holding History

RhumbLine Advisers’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-44
Closed -$53 – 4359
2023
Q2 		$53 Buy
+44
New +$54 ﹤0.01% 4372
2017
Q2 		– Sell
-458
Closed -$13K – 2961
2017
Q1 		$13K Buy
458
+28
+7% +$1.07K ﹤0.01% 2843
2016
Q4 		$20K Sell
430
-525
-55% -$30K ﹤0.01% 2845
2016
Q3 		$81K Buy
955
+17
+2% +$1.5K ﹤0.01% 2828
2016
Q2 		$81K Buy
938
+500
+114% +$52K ﹤0.01% 2938
2016
Q1 		$51K Hold
438
– – ﹤0.01% 2962
2015
Q4 		$62K Buy
+438
New +$64.1K ﹤0.01% 2990

Other funds holding VANI

TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RhumbLine Advisers's VANI Position: Q3 2023 in Review

RhumbLine Advisers sold out of Vivani Medical (VANI) in Q3 2023, closing a stake of 44 shares — an estimated $53 sold.

RhumbLine Advisers first reported a position in VANI in Q4 2015 and held it in 7 quarters. The position peaked at $81K in Q3 2016. 32 funds tracked by Wall St. Rank hold VANI as of Q3 2023.

  • RhumbLine Advisers reported no remaining Vivani Medical position as of Q3 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 44 Vivani Medical shares in Q3 2023, an estimated $53.
  • RhumbLine Advisers first reported a position in Vivani Medical in Q4 2015 and held it in 7 quarters.
  • RhumbLine Advisers's Vivani Medical position peaked at $81K in Q3 2016.
  • 32 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2023.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.